Document Format Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 1 | S-4/A | tm2227887-11_s4a.htm | S-4/A | 9892557 |
| 2 | EXHIBIT 10.35 | tm2227887d12_ex10-35.htm | EX-10.35 | 117771 |
| 3 | EXHIBIT 23.1 | tm2227887d12_ex23-1.htm | EX-23.1 | 1989 |
| 4 | EXHIBIT 23.3 | tm2227887d12_ex23-3.htm | EX-23.3 | 1483 |
| 5 | EXHIBIT 99.4 | tm2227887d12_ex99-4.htm | EX-99.4 | 2999 |
| 6 | GRAPHIC | lg_sesenbio-4c.jpg | GRAPHIC | 26508 |
| 7 | GRAPHIC | lg_carismatherapeutics-4c.jpg | GRAPHIC | 52313 |
| 8 | GRAPHIC | lg_mackenziepartners-bw.jpg | GRAPHIC | 19520 |
| 9 | GRAPHIC | tm2227887d8-tbl_pipelin4c.jpg | GRAPHIC | 123685 |
| 10 | GRAPHIC | tm2227887d8-tbl_oncolog4c.jpg | GRAPHIC | 151263 |
| 11 | GRAPHIC | tm2227887d8-fc_problem4c.jpg | GRAPHIC | 301235 |
| 12 | GRAPHIC | tm2227887d1-pht_tumor4c.jpg | GRAPHIC | 74270 |
| 13 | GRAPHIC | tm2227887d1-lc_human4c.jpg | GRAPHIC | 34969 |
| 14 | GRAPHIC | tm2227887d4-lc_contrl4c.jpg | GRAPHIC | 73816 |
| 15 | GRAPHIC | tm2227887d4-lc_reprogra4c.jpg | GRAPHIC | 183212 |
| 16 | GRAPHIC | tm2227887d1-pht_macrop4clr.jpg | GRAPHIC | 251991 |
| 17 | GRAPHIC | tm2227887d1-tbl_exvivo4c.jpg | GRAPHIC | 57154 |
| 18 | GRAPHIC | tm2227887d4-tbl_pipelin4c.jpg | GRAPHIC | 128200 |
| 19 | GRAPHIC | tm2227887d1-pht_key4c.jpg | GRAPHIC | 17906 |
| 20 | GRAPHIC | tm2227887d1-org_clinic4c.jpg | GRAPHIC | 76428 |
| 21 | GRAPHIC | tm2227887d4-bc_adverse4c.jpg | GRAPHIC | 688092 |
| 22 | GRAPHIC | tm2227887d4-lc_rapidly4c.jpg | GRAPHIC | 927375 |
| 23 | GRAPHIC | tm2227887d1-bc_single4clr.jpg | GRAPHIC | 25751 |
| 24 | GRAPHIC | tm2227887d4-bc_mostpreva4c.jpg | GRAPHIC | 1120837 |
| 25 | GRAPHIC | tm2227887d4-bc_frequen4c.jpg | GRAPHIC | 883842 |
| 26 | GRAPHIC | tm2227887d4-tbl_selct4c.jpg | GRAPHIC | 175146 |
| 27 | GRAPHIC | tm2227887d4-lc_pt4comp4c.jpg | GRAPHIC | 835610 |
| 28 | GRAPHIC | tm2227887d1-lc_asses4c.jpg | GRAPHIC | 50172 |
| 29 | GRAPHIC | tm2227887d1-lc_itcar4c.jpg | GRAPHIC | 23415 |
| 30 | GRAPHIC | tm2227887d1-pht_profnd4clr.jpg | GRAPHIC | 177151 |
| 31 | GRAPHIC | tm2227887d1-bc_119ct4c.jpg | GRAPHIC | 169909 |
| 32 | GRAPHIC | tm2227887d4-lc_ct1119a5494c.jpg | GRAPHIC | 631092 |
| 33 | GRAPHIC | tm2227887d1-lc_carmno4c.jpg | GRAPHIC | 64256 |
| 34 | GRAPHIC | tm2227887d1-bc_cyto4c.jpg | GRAPHIC | 121448 |
| 35 | GRAPHIC | tm2227887d1-lc_polar4c.jpg | GRAPHIC | 35856 |
| 36 | GRAPHIC | tm2227887d4-lc_persis4c.jpg | GRAPHIC | 182651 |
| 37 | GRAPHIC | tm2227887d4-lc_tumor4c.jpg | GRAPHIC | 105907 |
| 38 | GRAPHIC | tm2227887d4-fc_antibody4c.jpg | GRAPHIC | 1517204 |
| 39 | GRAPHIC | tm2227887d1-lc_poten4c.jpg | GRAPHIC | 34644 |
| 40 | GRAPHIC | tm2227887d1-pht_ipsc4clr.jpg | GRAPHIC | 68351 |
| 41 | GRAPHIC | tm2227887d1-bc_icar4c.jpg | GRAPHIC | 32157 |
| 42 | GRAPHIC | tm2227887d4-lc_ipscmacs4c.jpg | GRAPHIC | 55202 |
| 43 | GRAPHIC | tm2227887d1-pht_myloid4clr.jpg | GRAPHIC | 121994 |
| 44 | GRAPHIC | tm2227887d4-lc_lnp4c.jpg | GRAPHIC | 71874 |
| 45 | GRAPHIC | tm2227887d4-lc_2lnp4c.jpg | GRAPHIC | 66248 |
| 46 | GRAPHIC | tm2227887d4-lc_3lnp4c.jpg | GRAPHIC | 83140 |
| 47 | GRAPHIC | tm2227887d4-lc_4lnp4c.jpg | GRAPHIC | 70114 |
| 48 | GRAPHIC | tm2227887d4-lc_5lnp4c.jpg | GRAPHIC | 64773 |
| 49 | GRAPHIC | tm2227887d4-lc_6lnp4c.jpg | GRAPHIC | 81395 |
| 50 | GRAPHIC | tm2227887d1-pht_reprobw.jpg | GRAPHIC | 29917 |
| 51 | GRAPHIC | tm2227887d1-lc_macro4c.jpg | GRAPHIC | 54331 |
| 52 | GRAPHIC | tm2227887d4-fc_carm4c.jpg | GRAPHIC | 777890 |
| 53 | GRAPHIC | lg_svbsecurities-4c.jpg | GRAPHIC | 31277 |
| 54 | GRAPHIC | ft_svbsecurities-4c.jpg | GRAPHIC | 38020 |
| Complete submission text file | 0001104659-23-002376.txt | 24919557 |
EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-267891 | Film No.: 23519486
SIC: 2834 Pharmaceutical Preparations
